BTG Pactual Asset Management US LLC Cuts Stock Holdings in Kenvue Inc. $KVUE

by · The Markets Daily

BTG Pactual Asset Management US LLC lessened its holdings in Kenvue Inc. (NYSE:KVUE – Free Report) by 26.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 165,088 shares of the company’s stock after selling 58,833 shares during the quarter. BTG Pactual Asset Management US LLC’s holdings in Kenvue were worth $3,155,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in KVUE. Callan Family Office LLC acquired a new position in Kenvue during the second quarter worth about $835,000. Calamos Advisors LLC grew its position in shares of Kenvue by 24.1% in the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock valued at $57,771,000 after purchasing an additional 651,000 shares during the last quarter. State of Wyoming increased its stake in shares of Kenvue by 233.5% during the 4th quarter. State of Wyoming now owns 97,992 shares of the company’s stock worth $1,690,000 after purchasing an additional 68,609 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in shares of Kenvue by 21.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock worth $60,229,000 after purchasing an additional 618,720 shares in the last quarter. Finally, Nuance Investments LLC acquired a new position in shares of Kenvue during the 2nd quarter worth approximately $27,681,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of a number of analyst reports. Wall Street Zen cut Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. UBS Group dropped their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday, August 11th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Barclays upped their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Finally, Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $19.27.

Get Our Latest Analysis on KVUE

Kenvue Trading Down 0.1%

Shares of Kenvue stock opened at $19.15 on Monday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.82. The business’s fifty day moving average is $19.16 and its two-hundred day moving average is $18.25. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The firm has a market cap of $36.78 billion, a PE ratio of 22.01, a P/E/G ratio of 1.37 and a beta of 0.47.

Kenvue (NYSE:KVUE – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The business had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. Kenvue’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.29 EPS. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a $0.21 dividend. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 12th. This represents a $0.84 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 96.55%.

Kenvue Company Profile

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Featured Articles